Valuation: Anthem Biosciences Limited

Market Cap 468B 4.91B 4.39B 4.05B 3.67B 6.87B 6.99B 48.3B 19.28B 245B 18.43B 18.03B 774B P/E 2027 *
65.4x
P/E 2028 * 55.5x
Enterprise Value 462B 4.85B 4.34B 4B 3.63B 6.79B 6.9B 47.71B 19.04B 242B 18.2B 17.81B 765B EV / Sales 2027 *
18.1x
EV / Sales 2028 * 15x
Free-Float
19.11%
Yield 2027 *
0.24%
Yield 2028 * 0.24%
1 day-0.24%
1 week+3.05%
Current month-3.31%
1 month-2.46%
3 months+5.90%
6 months+7.21%
Current year+27.42%
1 week 783.35
Extreme 783.35
846.05
1 month 783.35
Extreme 783.35
898.65
Current year 579.15
Extreme 579.15
977.55
1 year 579.15
Extreme 579.15
977.55
3 years 579.15
Extreme 579.15
977.55
5 years 579.15
Extreme 579.15
977.55
10 years 579.15
Extreme 579.15
977.55
Manager TitleAgeSince
Chief Operating Officer 59 2006-09-26
Chief Tech/Sci/R&D Officer 60 2006-08-03
Chief Executive Officer 66 2006-06-12
Director TitleAgeSince
Chairman 66 2020-12-31
Director/Board Member 60 2006-08-03
Director/Board Member 59 2006-09-26
Change 5-day change 1-year change 3-year change Capi.($)
-0.24%+3.05%+16.28% - 4.92B
+6.63%+8.10%+67.50%+145.20% 1,148B
+1.53%+6.76%+47.22%+89.01% 652B
+1.68%+2.10%+27.80%+109.31% 505B
+0.73%+2.47%+53.85%+68.96% 384B
+3.83%-2.37%+68.14%+42.32% 348B
+2.38%+4.27%+33.81%+57.95% 294B
+2.26%+3.47%+5.21%+28.92% 264B
+1.97%+5.11%+57.74%+76.14% 244B
+4.03%+7.84%+40.49%+116.14% 197B
Average +1.51%+1.58%+41.80%+81.55% 404.21B
Weighted average by Cap. +1.38%+1.51%+49.54%+95.97%

Financials

2027 *2028 *
Net sales 25.48B 268M 239M 220M 200M 374M 381M 2.63B 1.05B 13.35B 1B 983M 42.21B 30.66B 322M 288M 265M 241M 451M 458M 3.17B 1.26B 16.06B 1.21B 1.18B 50.79B
Net income 7.17B 75.27M 67.33M 62.01M 56.28M 105M 107M 740M 295M 3.75B 282M 276M 11.87B 8.43B 88.51M 79.17M 72.92M 66.18M 124M 126M 871M 347M 4.41B 332M 325M 13.96B
Net Debt -5.72B -60.11M -53.77M -49.52M -44.94M -84.12M -85.54M -591M -236M -3B -226M -221M -9.48B -8.76B -92.04M -82.33M -75.83M -68.82M -129M -131M -905M -361M -4.59B -345M -338M -14.52B
Projected Income Statement - Annual - Anthem Biosciences Limited
Logo Anthem Biosciences Limited
Anthem Biosciences Limited is an India-based contract research, development and manufacturing organization (CRDMO) with fully integrated operations spanning across drug discovery, development and manufacturing. The Company’s segments include CRDMO and Speciality Ingredients. The Company helps new and established biotech’s and big pharma, develop, optimize and test proteins, monoclonal antibodies, peptides, large molecules, small molecules, toxins and others. In addition to product research and development, it helps test drugs for safety, efficacy (in vitro and in vivo), pre-clinical animal studies in a GLP facility, clone development, antibody drug conjugates, research and development and manufacture of highly potent compounds, flow chemistry-based production and large-scale commercial product manufacture. Its CRDMO Services include Large Molecules, Small Molecules, HPAPI, Peptides, Lipids, ADCs and Oligonucleotides.
Employees
2,282
Date Price Change Volume
26-10-29 ₹830.15 -0.24% 206,089
26-10-28 ₹832.15 -0.60% 65,491
26-10-27 ₹837.15 +1.81% 206,744
26-10-26 ₹822.25 +1.16% 183,681
26-10-23 ₹812.80 +1.50% 535,896
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Anthem Biosciences Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
830.15INR
Average target price
920.12INR
Spread / Average Target
+10.84%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Anthem Biosciences Limited
  1. Stock Market
  2. Stocks
  3. ANTHEM Stock